Company / Net Debt per Share
Adaptive Biotechnologies Corp Net Debt per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$0.38
FY2025
5-year range
$0.25 / $0.58
FY2022-FY2025
Trend
-34.8%
vs FY2024
Sector context
#42 of 82
Health Care
What the data says
At $0.38, Adaptive Biotechnologies Corp's net debt per share ranks #41 of 82 in the Health Care sector. Improved from $0.46 to $0.38 over the past 2 years.
Based on SEC 10-K filings.
0.38 in FY2025 with a 3-year CAGR of +14.9%.
Improved from $0.46 to $0.38 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- +14.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#41 of 82 in Health CareTop 49% of 82This company $0.38 Sector average $1.13
▼
-66.4% below sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 34.8% year-over-year.
- Ranks #42 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.38 | -34.8% |
| FY2024 | $0.58 | +27.1% |
| FY2023 | $0.46 | +83.4% |
| FY2022 | $0.25 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026